Orsense

Orsense Ltd.October 28, 2013

OrSense Non Invasive Hemoglobin Monitor Received CFDA Approval for Marketing in China
Petach Tikva, Israel, October 28, 2013 – OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, today announced that it has received China Food and Drug Administration approval for NBM-200, its non-invasive hemoglobin (Hb) system for anemia monitoring and hemorrhage detection.

Orsense Ltd.May 28, 2013

OrSense Non Invasive Hemoglobin Monitor Shown Safe and Accurate for Pre-Donation Screening in Blood Banks
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today that its non-invasive Hemoglobin (Hb) NBM-200 monitor was the topic of multiple recent studies highlighting the clinical value of the device. Four studies, from various countries around

Orsense Ltd.July 9, 2012

OrSense Introduces Glasswing, its Next-Generation, Wireless, Non-Invasive Hemoglobin Monitoring System for Anemia Screening
Cancun, Mexico, July 9, 2012 – OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced today at the 32nd International Congress of the International Society of Blood Transfusion (ISBT), in Cancun, Mexico, GlasswingTM, its next-generation, wireless, non-invasive hemoglobin (Hb)

OrSense Ltd.June 26, 2012

OrSense detects hemorrhage, anemia during pregnancy
Israel’s OrSense , a developer of monitors for non-invasive measurements of various blood parameters, announced successful clinical trial results for anemia screening and hemorrhage detection via non-invasive methods. Dr. Eran Hadar, of the Department of Maternal Fetal Medicine at Rabin Medical Center, said OrSenes’s NBM200 device was as accurate as

OrSense Ltd.October 20, 2011

OrSense’s Non-Invasive Hemoglobin Measurement System for Pre-Donation Screening of Anemia Delivers Superior Clinical Value Compared to Current MethodsRepresentatives of three hospitals and Red Cross blood donation centers will present data on OrSense’s non-invasive hemoglobin screening system at AABB
NES ZIONA, Israel, Oct 20, 2011  — OrSense Ltd., developer of monitors for non-invasive measurements of various blood